We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Ranibizumab

Australian Public Assessment Report

AusPAR

AusPAR: Ranibizumab [PDF, 942.86 KB]

AusPAR: Ranibizumab [Word, 1.32 MB]

Attachment: Product Information: Ranibizumab [PDF, 797.73 KB]

Attachment: Product Information: Ranibizumab [Word, 700.92 KB]

Attachment: Extract from the Clinical Evaluation Report: Ranibizumab [PDF, 3.87 MB]

Attachment: Extract from the Clinical Evaluation Report: Ranibizumab [Word, 4.57 MB]

Device/Product Name

Lucentis

Active ingredients

Ranibizumab

AusPAR Date

14 October 2014

Published

9 December 2014

Submission Number

PM-2013-00985-1-5

Submission Type

Extension of indications

Decision

Approved